NSE filing, NSE: RNPL. Summary written from the filing by ALFA Finder's alert engine.
Renol Polychem Ltd: key numbers
- Share price
- ₹59.60
- Market cap
- ₹72.02 Cr
- Revenue (annual)
- ₹89.99 Cr
- Net profit (annual)
- ₹8.25 Cr
- P/E (TTM)
- 8.7×Sector 34.1×
- Promoter holding
- 51.10%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Renol Polychem Ltd
All →Renol Polychem Other Announcement
Renol Polychem Limited has filed a routine compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Renol Polychem Annual General Meeting
Renol Polychem Limited held its 3rd Annual General Meeting on September 30, 2026, through video conferencing to transact ordinary and special business.
Renol Polychem Other Announcement
Renol Polychem Limited has appointed H Togadiya & Associates as Secretarial Auditor, N. B. Sakhara & Co. as Internal Auditor, and Sunit M Chhatbar & Co. as Statutory Auditor.
Renol Polychem Board Meeting Outcome
Renol Polychem Limited announced the outcome of its board meeting held on September 07, 2026, approving the AGM notice and various auditor appointments for upcoming years.
Renol Polychem Annual General Meeting
Renol Polychem Limited has issued a notice for its 3rd Annual General Meeting, scheduled for September 30, 2026. Shareholders will consider various routine and special business items.
Renol Polychem H2 FY26 Results: Net Profit ₹5.9 Cr, Up 110.7% YoY
Renol Polychem Ltd reported revenue from operations of ₹49.9 Cr (+49.4% YoY) and net profit of ₹5.9 Cr (+110.7% YoY) for H2 FY26.
- Key figure
- Net profit ₹5.9 Cr · +110.7% YoY
Other other announcement announcements
All →NIIT Learning Systems Other Announcement
NIIT Learning Systems board recommended appointing Price Waterhouse Chartered Accountants LLP as statutory auditor for five years from the 25th AGM. The incumbent S. R. Batliboi firm completes its second term.
- Execution
- Five consecutive years, from the 25th AGM (2027) until the 30th AGM (2032)
Senores Pharmaceuticals Other Announcement
Senores Pharmaceuticals appointed Talati and Talati LLP as Statutory Auditor for a 60-month term, effective 29 October 2026. The appointment was approved at the board meeting held the same day.
- Execution
- 60 months
Magson Retail & Distribution Other Announcement
Magson Retail submitted its Regulation 76 Reconciliation of Share Capital Audit Report for the quarter ended 30 September 2026. The report shows a 9,15,940 share difference between issued and listed capital, pending exchange listing approval.
Ekennis Software Service Other Announcement
Ekennis Software declared Regulation 23 related party transaction rules non-applicable for H1 FY27, as its paid-up capital and net worth are below SME thresholds. A CA certificate confirms the figures.
Shri Gang Industries and Allied Products Other Announcement
Shri Gang Industries filed its quarterly shareholding pattern dated 23 October 2026. The filing notes pledges, a warrant conversion, and a deceased promoter's shares moved to a nominee.
P N Gadgil Jewellers Other Announcement
P N Gadgil Jewellers filed a Monitoring Agency Report on its QIP proceeds for the quarter ended 30 September 2026. The agency reports no deviation from the stated objects of the Rs 7,000 million issue.